Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: A multicenter, randomized trial

World Journal of Urology

Volumn 29, Issue 3, 2011, Pages 381-385

  Chen, Yong ^a   Wu, Xiaohou ^a   Liu, Jia ^b   Tang, Wei ^a   Zhao, Tao ^c   Zhang, Jianhua ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Reproductive Health Counseling Center   (China)

^c Fuling Central Hospital   (China)

Author keywords

Alpha blockers; Efficacy; Prostatitis; Tamsulosin

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; SULFONAMIDE; TAMSULOSIN;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; LONGITUDINAL STUDY; MALE; MULTICENTER STUDY; PELVIS PAIN SYNDROME; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; LONGITUDINAL STUDIES; MALE; PELVIC PAIN; PROSTATITIS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 79957459503     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0537-3     Document Type: Article

References (20)

1. Nickel JC, Downey J, Hunter D, Clark J (2001) Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 165: 842-845.
2. Cornel EB, van Haarst EP, Schaarsbergc RW, Geels J (2005) The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur Urol 47: 607-611.
3. Ishigooka M, Zermann DH, Doggweiler R, Schmidt RA (2000) Similarity of distributions of spinal c-Fos and plasma extravasation after acute chemical irritation of the bladder and the prostate. J Urol 164: 1751-1756.
4. Nickel JC (2006) Alpha-blockers for the treatment of prostatitis-like syndromes. Rev Urol 8(suppl 4): S26-S34.
5. Tugcu V, Tasci AI, Fazlioglu A, Gurbuz G, Ozbek E, Sahin S, Kurtulus F, Cek M (2006) A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 51(4): 1113-1118.
6. Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M et al (2008) Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359(25): 2663-2673.
7. Nickel JC, Narayan P, McKay J, Doyle C (2004) Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 171(4): 1594-1597.
8. Cheah PY, Liong ML, Yuen KH et al (2004) Initial, long term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology 64: 881-886.
9. Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al (1999) The National Institutes of health chronic prostatitis symptom index (NIH-CPSI): development and validation of a new outcomes measure. J Urol 162: 369-375.
10. Propert KJ, Litwin MS, Wang Y et al (2006) Responsiveness of the national institutes of health chronic prostatitis symptom index (NIH-CPSI). Qual Life Res 15: 299-305.
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49: 822-830.
12. Duclos AJ, Lee CT, Shoskes DA (2007) Current treatment options in the management of chronic prostatitis. Ther Clin Risk Manag 3: 507-512.
13. Liao LM, Shi BY, Liang CQ (1999) Ambulatory urodynamic monitoring of external urethral sphincter behavior in chronic prostatitis patients. Asian Journal of Andrology 1(4): 215-217.
14. Andersson KE, Gratzke C (2007) Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 4: 368-378.
15. Ishigooka M, Nakada T, Hashimoto T et al (2002) Spinal substance P immunoreactivity is enhanced by acute chemical stimulation of the rat prostate. Urology 59(1): 139-144.
16. Geppetti P, Nassini R, Materazzi S, Benemei S (2008) The concept of neurogenic inflammation. BJU Int 101(Suppl): 2-6.
17. Nickel JC, Narayan P, McKay J, Doyle C (2004) Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 171: 1594-1597.
18. Mehik A, Alas P, Nickel JC, Sarpola A, Helstrom PJ (2003) Alfuzosin treatment for chronicprostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 62: 425-429.
19. Chen Y, Song B, Jin XY, Xiong EQ, Zhang JH (2005) Possible mechanism of referred pain in the perineum and pelvis associated with the prostate in rats. J Urol 174: 2405-2408.
20. Li NC, Chen S, Yang XH, Du LD, Yang JY, Na YQ (2003) Efficacy of low-dose tamsulosin in chinese patients with symptomatic benign prostatic hyperplasia. Clin Drug Invest 23(12): 781-787.